Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Sell
10,729
-6,866
-39% -$481K 0.01% 693
2026
Q1
$1.33M Sell
17,595
-7,853
-31% -$627K 0.03% 481
2025
Q4
$2.01M Sell
25,448
-18,542
-42% -$1.43M 0.04% 349
2025
Q3
$3.28M Sell
43,990
-11,699
-21% -$976K 0.1% 200
2025
Q2
$4.92M Buy
55,689
+42,466
+321% +$3.81M 0.16% 155
2025
Q1
$1.26M Sell
13,223
-3,938
-23% -$353K 0.09% 182
2024
Q4
$1.46M Buy
+17,161
New +$1.55M 0.09% 186

Other funds holding ALC

Callan Family Office's ALC Position: Q2 2026 in Review

Callan Family Office reduced its Alcon (ALC) stake by 39% in Q2 2026, selling an estimated $481K and leaving 10,729 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #693.

Callan Family Office first reported a position in ALC in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.92M in Q2 2025. 634 funds tracked by Wall St. Rank hold ALC as of Q2 2026.

  • Callan Family Office held 10,729 shares of Alcon worth $720K as of Q2 2026.
  • Callan Family Office sold 6,866 Alcon shares in Q2 2026, an estimated $481K.
  • Alcon made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #693 holding.
  • Callan Family Office first reported a position in Alcon in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Alcon position peaked at $4.92M in Q2 2025.
  • 634 funds tracked by Wall St. Rank held Alcon as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.